6 Feb 2004

UCB - Acquisition of innovative treatments in allergy

Read More
4 Feb 2004

UCB Group - Provisional Results for 2003: Increase in Net Profit.

Read More
18 Dec 2003

UCB: Confidence in the future - Significant Programmes for R&D and Investment for the Year 2004.

Read More
22 Oct 2003

UCB: Third quarter Zyrtec sales in the US

Read More
30 Sep 2003

UCB : Closing of the sale of Methylamines & Derivatives Activities

Read More
24 Sep 2003

UCB Pharma enters European licensing agreement with Watson

Read More
22 Sep 2003

UCB : New Director-General of the Pharma Sector

Read More
16 Sep 2003

UCB invests in new production unit of Radcure monomers

Read More
16 Aug 2003

UCB : Sale of Methylamines & Derivatives Activities

Read More
29 Jul 2003

UCB Group : 2003 first half-year result

Read More
Subscribe to